Clinical Study
-
Biologics
Prosidyan® FIBERGRAFT® Achieves High Fusion Rate in Multi-Center Clinical Study Presented at Top Neurosurgery Conference
FIBERGRAFT® BG Matrix Achieved 96.3% Fusion Rate in Posterolateral Spine Fusion Clinical Study NEW PROVIDENCE, N.J. (PRWEB) AUGUST 26, 2021 Prosidyan,…
Read More » -
Extremities
CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects
According to a Two-Year Randomized and Controlled Multinational IDE Study KFAR SABA, Israel, Aug. 3, 2021 /PRNewswire/ — CartiHeal Ltd, developer of Agili-C™,…
Read More » -
Biologics
Bone Therapeutics provides update on the progress of clinical studies
REGULATED INFORMATION JTA-004 Phase III top-line results planned first half September ALLOB Phase IIb currently on track but recruitment slow…
Read More » -
Spine
SI-BONE, Inc. Announces Publication of iFuse-3D Implant Clinical Study Results Showing Accelerated Fusion, Immediate and Sustained Clinical Improvements and Reduction in Opioid Use
There are now 95 peer-reviewed publications demonstrating the safety, effectiveness, biomechanical or economic benefits of iFuse Technology™ July 7, 2021…
Read More » -
Biologics
DiscGenics Completes Patient Enrollment in Japanese Clinical Study of Cell Therapy for Disc Degeneration as US Study Achieves One-Year Follow-up Milestone
SALT LAKE CITY and TOKYO, April 27, 2021 /PRNewswire/ — DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate…
Read More » -
Spine
NuVasive and the International Spine Study Group Foundation Announce Expanded Long-Term Partnership with Initiation of Additional Clinical Studies
SAN DIEGO, March 16, 2021 /PRNewswire/ –NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine…
Read More » -
Biologics
AlloSource Announces First Patients Implanted With AlloWrap Amniotic Membrane In Clinical Study For Two-Level Anterior Cervical Discectomy And Fusion Procedures
CENTENNIAL, Colo., Feb. 23, 2021 /PRNewswire/ –AlloSource®, one of the largest allograft providers in the U.S., creating innovative cellular and tissue products,…
Read More » -
Biologics
Bone Therapeutics treats first patient in ALLOB Phase IIb tibial fracture study
Gosselies, Belgium, 12 January 2020, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet…
Read More » -
Spine
NuVasive’s X360 Procedural Approach Validated in Clinical Study Published in The Spine Journal Finding Single-Position Spine Surgery Improves Operative Efficiency While Reducing Complications and Length of Hospital Stay
SAN DIEGO, Jan. 6, 2021 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally…
Read More » -
Regulatory
MCRA CRO Assists Simplify Medical, Inc. on the Fastest Spine PMA Ever Approved by the FDA
WASHINGTON, Oct. 1, 2020 /PRNewswire/ — MCRA, LLC, a leading medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S.…
Read More » -
Biologics
Novel Tissue Preservation Method Improves Outcomes in Cartilage Transplant Procedures in the Knee
COLUMBIA, Mo. (July 8, 2020) ― A University of Missouri study on clinical outcomes after biologic knee restoration surgery found…
Read More » -
Recon
Positive results from follow-up of 30 patients in a Swedish multicentre clinical trial of the Episealer® Knee implant
Episurf Medical (Nasdaq: EPIS B) March 8, 2020 – Today announces that results from a clinical study with follow-up of…
Read More » -
Recon
Clinical Study Shows Improved Clinical Outcomes, High Rate of Return to Activity for Patients with Arthrosurface OVO® with Inlay Glenoid Shoulder Arthroplasty System
FRANKLIN, Mass., March 10, 2020 /PRNewswire/ — A new study published in the Journal of Shoulder and Elbow Surgery found that younger, active adults who…
Read More » -
Biologics
DiscGenics Announces Completion of Enrollment in U.S. Phase 1/2 Clinical Trial of Discogenic Cell Therapy for Degenerative Disc Disease
SALT LAKE CITY, March 4, 2020 /PRNewswire/ — DiscGenics, Inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate…
Read More » -
Spine
Clinical Study Demonstrates Favorable Patient Outcomes with the FlareHawk® Expandable Cage
PALM BEACH GARDENS, Fla., March 3, 2020 (GLOBE NEWSWIRE) – Integrity Implants Inc., a privately held medical device company dedicated…
Read More »